Insider Transactions in Q4 2025 at Kura Oncology, Inc. (KURA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2025
|
Kathleen Ford Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,902
-6.15%
|
$75,922
$11.18 P/Share
|
|
Nov 14
2025
|
Thomas James Doyle SVP, Finance & Accounting |
SELL
Open market or private sale
|
Direct |
4,539
-3.37%
|
$49,929
$11.18 P/Share
|
|
Nov 14
2025
|
Mollie Leoni Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,485
-6.43%
|
$170,335
$11.18 P/Share
|
|
Nov 14
2025
|
Brian T. Powl Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,887
-5.98%
|
$97,757
$11.18 P/Share
|
|
Nov 14
2025
|
Teresa Brophy Bair Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,804
-4.47%
|
$96,844
$11.18 P/Share
|
|
Nov 13
2025
|
Kathleen Ford Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,900
+30.34%
|
-
|
|
Nov 13
2025
|
Thomas James Doyle SVP, Finance & Accounting |
BUY
Grant, award, or other acquisition
|
Direct |
24,967
+15.63%
|
-
|
|
Nov 13
2025
|
Mollie Leoni Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
82,500
+25.51%
|
-
|
|
Nov 13
2025
|
Brian T. Powl Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,900
+24.76%
|
-
|
|
Nov 13
2025
|
Troy Edward Wilson President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
182,500
+29.83%
|
-
|
|
Nov 13
2025
|
Teresa Brophy Bair Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,900
+19.89%
|
-
|